on OXURION (EBR:OXUR)
Oxurion Publishes its 2025 Annual Report
Leuven, Belgium – Oxurion NV, a Belgian pharmaceutical company listed on Euronext Brussels, has released its annual report for the financial year ending December 31, 2025. This document is available in the "Investors" section of their website and can be downloaded in PDF format.
Simultaneously, Oxurion convened its Annual General Meeting of Shareholders, details of which are available on its dedicated web portal. Oxurion, which specializes in acquiring majority stakes in European pharmaceutical subcontractors, seeks to build an integrated group focused on the healthcare sector.
Certain forward-looking statements in the press release refer to risks and uncertainties. The company cautions that future results may differ from current expectations.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news